fr   en
Clinical Studies
Phase :    
Announcement :   
Select a Pharma :
Select a product :
Select a disease :
Choose date:
[<<]      «      47   |   48   |   49   |   50   |   51   |   52   |   53   |   54   |   55   |   56   |   57      »      [57]
Date Phase Anouncement Biotech Pharma Product Disease Country Other
2006-11-13 II Launch Avontec (Germany)   AVT-01 (double-strand oligonucleotide inhibiting the STAT-1 transcription factor) asthma United Kingdom and Romania See details
2006-11-13 II Result Transgene (France)   TG 4001 therapeutic vaccine Uterine cervical cancer   See details
2006-11-08 I Launch Argenta Discovery (UK)   ADC4022 chronic obstructive pulmonary disease (COPD), severe asthma   See details
2006-11-07 III Launch Oxford BioMedica (UK)   Trovax® (therapeutic vaccine - attenuated version of vaccinia virus modified to deliver the gene for the 5T4 tumour antigen) metastatic renal cell carcinoma USA, EU and Eastern Europe See details
2006-10-25 I Launch Crucell (The Netherlands) Aeras Global TB Vaccine Foundation   BCG-Ad35 (AdVac®-based tuberculosis vaccine - Aeras-402) tuberculosis USA See details
2006-10-17 II Launch KeyNeurotek Pharmaceuticals (Germany)   KN38-7271 (cannabinoid receptor agonist, activating the CB1 and CB2 receptors) traumatic brain injury (TBI) 12 centres in Europe, including Germany See details
2006-10-16 II Result Wilex (Germany)   Rencarex® This chimeric monoclonal antibody targets the MN/CA IX antigen (or G250 antigen) which is expressed on over 90% of clear cell RCCs, but not on healthy kidney tissue. metastatic renal cell cancer   See details
2006-10-12 II Launch Mondobiotech (Switzerland)   Aviptadil administered by inhalation. The drug is a synthetic version of human intestinal vasoactive peptide. pulmonary sarcoidosis Germany See details
2006-10-11 I Result Antisoma (UK)   AS1411 renal cancer   See details
2006-10-10 I Result Immatics (Germany)   IMA901 (a combination of 10 antigens displayed by the renal cells of cancer patients) kidney cancer Germany, United Kingdom, Switzerland See details
2006-10-09 II Launch Heidelberg Pharma (Germany)   fosalvudine tidoxil (a reverse transcriptase inhibitor) AIDS   See details
2006-09-27 II Launch Trubion Pharmaceuticals (USA) Wyeth (USA) TRU-015 (immunotherapy) rheumatoid arthritis   See details
2006-09-25 I Launch Pevion Biotech (Switzerland)/Bio Life Science (Austria)   therapeutic vaccine based on the use of antigens derived from the HER-2/neu oncoprotein breast cancer (protection against the reappearance of a tumour in female patients having already been treated) Austria See details
2006-09-22 IIa Launch Thrombogenics (Belgium)   microplasmin acute stroke Germany See details
2006-09-20 II Result Cytos Biotechnology (Switzerland)   CYT003-QbG10 (immunotherapy) allergic diseases Switzerland See details
[<<]      «      47   |   48   |   49   |   50   |   51   |   52   |   53   |   54   |   55   |   56   |   57      »      [57]